Azitra Inc Sustainability Reports
Azitra, Inc. is an early-stage clinical biopharmaceutical company that leverages genetic engineering and the human skin microbiome to develop precision dermatology therapies.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
2 reports from 2023 to 2024
Company Profile
Azitra, Inc. is an early-stage clinical biopharmaceutical company that leverages genetic engineering and the human skin microbiome to develop precision dermatology therapies.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
